Atlas Trials

Observational Study That Will Analyse the Spread and Stratification of Lung Cancer Risk Using Artificial Intelligence

Clinical trial NCT07617636 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07617636
Sponsor
AstraZeneca
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer
Start date
2026-07-31
Primary completion
2027-08-31
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.